NPR Health
Primary care doctors raise alarm as telehealth companies get involved in obesity drugs
Telehealth companies are muscling into the obesity drug market, positioning themselves as lifestyle coaches to help patients maximize results on GLP-1 medications. The catch: employers footing the bill are pressuring these same companies to act as gatekeepers, limiting who gets access to the drugs. Primary care physicians warn this dual role creates a dangerous conflict of interest that could compromise patient care.
Read article →NPR Health
Want obesity drugs covered by insurance? Telehealth companies have a big say
Telehealth companies have emerged as unlikely gatekeepers in the booming obesity drug market, sitting at the intersection of patient care and employer cost control. While these platforms provide the lifestyle coaching that helps patients maximize results on GLP-1 medications, they are simultaneously under pressure from employers to rein in prescription spending. The dynamic raises pointed questions about whether clinical decisions are being shaped by financial incentives rather than patient need.
Read article →Medical Xpress
Type 1 diabetes diagnoses surge among Puerto Rican teens
Type 1 diabetes diagnoses among Puerto Rican teenagers more than doubled between 2009 and 2021, climbing at an average annual rate of 4.1% and remaining elevated through 2024. The findings, presented at the Endocrine Society's annual meeting, signal a troubling and sustained public health trend in the region. Researchers did not identify a clear cause, making the surge an urgent target for further investigation.
Read article →Medical Xpress
Glucosamine supplements may speed memory loss from Alzheimer's, new research shows
Glucosamine, a widely used supplement often taken for joint pain, may pose serious risks for people with Alzheimer's disease. A new study published in Nature Metabolism found that Alzheimer's patients who took glucosamine were 25% more likely to die within five years compared to those who avoided it. The findings raise urgent questions about supplement safety in vulnerable populations and could prompt physicians to reconsider routine use among this group.
Read article →Medical Xpress
Endocrine-disrupting chemicals found in breast milk and infant urine up to age 6 months
Endocrine-disrupting chemicals that interfere with hormonal development have been detected in breast milk and infant urine from birth through six months of age, according to new research presented at ENDO 2026. The findings raise fresh questions about early-life chemical exposure during a critical window of hormonal and neurological development. Researchers are calling for closer scrutiny of how these compounds enter the maternal and infant supply chain.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →